MARKET WIRE NEWS
  1. Home
  2. Stock
  3. VSTM
  4. News
  5. Verastem Navigating Critical Steps In Commercializat
VSTM
Quote
Short
News
Articles
Message Board

Verastem: Navigating Critical Steps In Commercialization And Development (Downgrade)

Source: SeekingAlpha

2025-10-07 23:57:48 ET

Topline Summary and Update

Read the full article on Seeking Alpha

For further details see:

Verastem: Navigating Critical Steps In Commercialization And Development (Downgrade)
Verastem Inc.

NASDAQ: VSTM

VSTM Trading

-1.39% G/L:

$5.695 Last:

666,454 Volume:

$5.82 Open:

mwn-app Ad 300

VSTM Latest News

March 17, 2026 06:03:00 pm
Verastem Oncology Announces Late Breaking and Regular Abstracts Accepted for Presentation at the AACR Annual Meeting 2026
March 17, 2026 04:44:00 pm
Verastem Oncology Announces Abstracts Accepted for Presentation on AVMAPKI(TM) FAKZYNJA(TM) (avutometinib capsules; defactinib tablets) Combination Therapy at the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancers
March 05, 2026 11:57:23 am
Verastem (VSTM) Q4 2025 Earnings Call Transcript
March 04, 2026 04:01:00 pm
Verastem Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Business Updates

VSTM Stock Data

$424,027,638
66,108,246
1.4%
15
N/A
Biotechnology & Life Sciences
Healthcare
https://www.verastem.com
US
Needham

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App